BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17141979)

  • 21. Intravoxel incoherent motion diffusion-weighted imaging in head and neck squamous cell carcinoma: assessment of perfusion-related parameters compared to dynamic contrast-enhanced MRI.
    Fujima N; Yoshida D; Sakashita T; Homma A; Tsukahara A; Tha KK; Kudo K; Shirato H
    Magn Reson Imaging; 2014 Dec; 32(10):1206-13. PubMed ID: 25131628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion-weighted imaging in the head and neck region: usefulness of apparent diffusion coefficient values for characterization of lesions.
    Şerifoğlu İ; Oz İİ; Damar M; Tokgöz Ö; Yazgan Ö; Erdem Z
    Diagn Interv Radiol; 2015; 21(3):208-14. PubMed ID: 25910284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of accuracy of intravoxel incoherent motion and apparent diffusion coefficient techniques for predicting malignancy of head and neck tumors using half-Fourier single-shot turbo spin-echo diffusion-weighted imaging.
    Sakamoto J; Imaizumi A; Sasaki Y; Kamio T; Wakoh M; Otonari-Yamamoto M; Sano T
    Magn Reson Imaging; 2014 Sep; 32(7):860-6. PubMed ID: 24832359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
    Mundada P; Varoquaux AD; Lenoir V; de Vito C; Dulguerov N; Ailianou A; Caparrotti F; Becker M
    Eur J Radiol; 2018 Apr; 101():162-169. PubMed ID: 29571791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective comparative study of MRI including diffusion-weighted images versus FDG PET-CT for the detection of recurrent head and neck squamous cell carcinomas after (chemo)radiotherapy.
    Driessen JP; Peltenburg B; Philippens MEP; Huijbregts JE; Pameijer FA; de Bree R; Janssen LM; Terhaard CHJ
    Eur J Radiol; 2019 Feb; 111():62-67. PubMed ID: 30691667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.
    Hwang I; Choi SH; Kim YJ; Kim KG; Lee AL; Yun TJ; Kim JH; Sohn CH
    AJNR Am J Neuroradiol; 2013 Dec; 34(12):2343-8. PubMed ID: 23811978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.
    Schouten CS; de Graaf P; Alberts FM; Hoekstra OS; Comans EF; Bloemena E; Witte BI; Sanchez E; Leemans CR; Castelijns JA; de Bree R
    Oral Oncol; 2015 May; 51(5):541-7. PubMed ID: 25725587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
    Razek AA; Megahed AS; Denewer A; Motamed A; Tawfik A; Nada N
    Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma.
    Lambrecht M; Van Calster B; Vandecaveye V; De Keyzer F; Roebben I; Hermans R; Nuyts S
    Radiother Oncol; 2014 Mar; 110(3):429-34. PubMed ID: 24630535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
    Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C
    Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of diffusion MRI characteristics of cervical lymph nodes as disease classifier between patients with head and neck squamous cell carcinoma and healthy volunteers.
    Papoutsaki MV; Sidhu HS; Dikaios N; Singh S; Atkinson D; Kanber B; Beale T; Morley S; Forster M; Carnell D; Mendes R; Punwani S
    NMR Biomed; 2021 Nov; 34(11):e4587. PubMed ID: 34240782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences.
    Bruegel M; Gaa J; Waldt S; Woertler K; Holzapfel K; Kiefer B; Rummeny EJ
    AJR Am J Roentgenol; 2008 Nov; 191(5):1421-9. PubMed ID: 18941080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Image Quality and ADC Assessment in Turbo Spin-Echo and Echo-Planar Diffusion-Weighted MR Imaging of Tumors of the Head and Neck.
    Panyarak W; Chikui T; Yamashita Y; Kamitani T; Yoshiura K
    Acad Radiol; 2019 Oct; 26(10):e305-e316. PubMed ID: 30528753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma.
    de Bondt RB; Hoeberigs MC; Nelemans PJ; Deserno WM; Peutz-Kootstra C; Kremer B; Beets-Tan RG
    Neuroradiology; 2009 Mar; 51(3):183-92. PubMed ID: 19137282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
    Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
    Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
    Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
    Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck.
    Kim S; Loevner L; Quon H; Sherman E; Weinstein G; Kilger A; Poptani H
    Clin Cancer Res; 2009 Feb; 15(3):986-94. PubMed ID: 19188170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
    Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
    J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.